These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1445748)

  • 1. Tissue polypeptide antigen in breast cancer cytosol: a new effective prognostic indicator.
    Gion M; Mione R; Pappagallo GL; Gatti C; Nascimben O; Brandes A; Vinante O; Bruscagnin G
    Eur J Cancer; 1992; 29A(1):66-9. PubMed ID: 1445748
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue polypeptide antigen in tumor cytosol: a new prognostic indicator in primary breast cancer.
    Gion M; Mione R; Gatti C; Dittadi R; Leon A; Castiglioni C; Nascimben O; Bruscagnin G
    Breast Cancer Res Treat; 1990 Nov; 17(1):15-21. PubMed ID: 1965704
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative measurement of soluble cytokeratin fragments in tissue cytosol of 599 node negative breast cancer patients: a prognostic marker possibly associated with apoptosis.
    Gion M; Boracchi P; Dittadi R; Biganzoli E; Peloso L; Gatti C; Paccagnella A; Rosabian A; Vinante O; Meo S
    Breast Cancer Res Treat; 2000 Feb; 59(3):211-21. PubMed ID: 10832591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue polypeptide antigen and tissue polypeptide specific antigen in primary breast cancer. Evaluation in serum and tumour tissue.
    Gion M; Mione R; Barioli P; Sartorello P; Capitanio G
    Eur J Clin Chem Clin Biochem; 1994 Oct; 32(10):779-87. PubMed ID: 7865616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical parameters for prognostic evaluation in patients with breast cancer.
    Gion M; Mione R; Pappagallo GL; Gatti C; Nascimben O; Sampognaro E; Meo S
    Anticancer Res; 1994; 14(2B):693-8. PubMed ID: 8010728
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carcinoembryonic antigen, ferritin, and tissue polypeptide antigen in serum and tissue. Relationship with the receptor content in breast carcinoma.
    Gion M; Mione R; Dittadi R; Fasan S; Pallini A; Bruscagnin G
    Cancer; 1986 Mar; 57(5):917-22. PubMed ID: 3943025
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CA-15.3, TPA and MCA as markers for breast cancer.
    Barak M; Steiner M; Finkel B; Abrahamson J; Antal S; Gruener N
    Eur J Cancer; 1990; 26(5):577-80. PubMed ID: 2144745
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of PS2 and cathepsin D in 710 human primary breast tumors: multivariate analysis.
    Foekens JA; van Putten WL; Portengen H; de Koning HY; Thirion B; Alexieva-Figusch J; Klijn JG
    J Clin Oncol; 1993 May; 11(5):899-908. PubMed ID: 8487052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is tissue polypeptide antigen still a useful tumor marker in breast carcinoma? Comparison with CA15.3 and MCA.
    Gion M; Mione R; Gatti C; Dittadi R; Leon A; Nascimben O; Pizzorno B; Bruscagnin G
    Tumori; 1990 Aug; 76(4):360-4. PubMed ID: 2399565
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PS2 in breast cancer--alternative or complementary tool to steroid receptor status? Evaluation of 446 cases.
    Gion M; Mione R; Pappagallo GL; Gatti C; Nascimben O; Bari M; Leon AE; Vinante O; Bruscagnin G
    Br J Cancer; 1993 Aug; 68(2):374-9. PubMed ID: 8347494
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cathepsin D levels in primary breast cancers: relationship with epidermal growth factor receptor, oestrogen receptor and axillary nodal status.
    Sacks NP; Smith K; Norman AP; Greenall M; LeJeune S; Harris AL
    Eur J Cancer; 1993; 29A(3):426-8. PubMed ID: 8398346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The prognostic significance of cathepsin D in primary breast cancer].
    Crombach G; Ingenhorst A; Göhring UJ; Scharl A; Schaeffer HJ; Stützer H; Bolte A
    Geburtshilfe Frauenheilkd; 1994 Oct; 54(10):545-51. PubMed ID: 8001750
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationship between cytosol TPS, TPA and cell proliferation.
    Gion M; Mione R; Becciolini A; Balzi M; Correale M; Piffanelli A; Giovannini G; Saccani Jotti G; Fontanesi M
    Int J Biol Markers; 1994; 9(2):109-14. PubMed ID: 7930761
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Polyadenylate polymerase enzymatic activity in mammary tumor cytosols: A new independent prognostic marker in primary breast cancer.
    Scorilas A; Talieri M; Ardavanis A; Courtis N; Dimitriadis E; Yotis J; Tsiapalis CM; Trangas T
    Cancer Res; 2000 Oct; 60(19):5427-33. PubMed ID: 11034084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of steroid receptors, pS2 and cathepsin D on the outcome of elderly breast cancer patients: an exploratory investigation.
    Coradini D; Biganzoli E; Boracchi P; Bombardieri E; Seregni E; De Palo G; Martelli G; Di Fronzo G
    Int J Cancer; 1998 Aug; 79(4):305-11. PubMed ID: 9699519
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasminogen activator inhibitor-1 and prognosis in primary breast cancer.
    Foekens JA; Schmitt M; van Putten WL; Peters HA; Kramer MD; Jänicke F; Klijn JG
    J Clin Oncol; 1994 Aug; 12(8):1648-58. PubMed ID: 8040677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of cytosolic p53 protein in breast cancer.
    Montero S; Guzmán C; Vargas C; Ballestín C; Cortés-Funes H; Colomer R
    Tumour Biol; 2001; 22(5):337-44. PubMed ID: 11553865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma and tissue CEA and TPA markers in operable breast cancer. Preliminary results.
    Saccani Jotti G; Bombardieri E; Fontanesi M; Becchi G; Bocchi P; Palli D; Rusca M; Rusconi A; Pizzorno B; Tardini A
    Tumori; 1988 Dec; 74(6):681-8. PubMed ID: 3232213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Thrombospondin-1 and -2 in node-negative breast cancer: correlation with angiogenic factors, p53, cathepsin D, hormone receptors and prognosis.
    Gasparini G; Toi M; Biganzoli E; Dittadi R; Fanelli M; Morabito A; Boracchi P; Gion M
    Oncology; 2001; 60(1):72-80. PubMed ID: 11150912
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of the tissue polypeptide antigen in lung cancer.
    Buccheri G; Ferrigno D
    Chest; 1992 May; 101(5):1287-92. PubMed ID: 1582286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.